NeuroSense Therapeutics Ltd. Costs and Expenses
NeuroSense Therapeutics Ltd. (NRSN) reported Costs and Expenses of $77.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2023-03-22
| Period end | Costs and Expenses 12 month |
|---|---|
| 2022-12-31 | $77.00K 20-F · filed 2023-03-22 |
| 2021-12-31 | $19.00K 20-F · filed 2023-03-22 |